BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Beyazit Y, Kekilli M, Haznedaroglu IC, Kayacetin E, Basaranoglu M. Ankaferd hemostat in the management of gastrointestinal hemorrhages. World J Gastroenterol 2011; 17(35): 3962-3970 [PMID: 22046083 DOI: 10.3748/wjg.v17.i35.3962]
URL: https://www.wjgnet.com/1007-9327/full/v17/i35/3962.htm
Number Citing Articles
1
Emre Huri, Engin Dogantekin, Murvet Hayran, Umit Yavuz Malkan, Mine Ergun, Aysegul Firat, Yavuz Beyazit, Huseyin Ustun, Murat Kekilli, Mumtaz Dadali, Muzeyyen Astarci, Ibrahim C. Haznedaroglu. Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue levelSpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3625-z
2
Cagri Akalin, Serdar Kuru, Aziz Mutlu Barlas, Kemal Kismet, Bugra Kaptanoglu, Aydin Demir, Hesna Muzeyyen Astarci, Huseyin Ustun, Ertugrul Ertas. Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental studyInternational Wound Journal 2014; 11(1): 64 doi: 10.1111/j.1742-481X.2012.01063.x
3
Rafiye Ciftciler, Ali Erdinc Ciftciler, Umit Yavuz Malkan, Ibrahim C Haznedaroglu. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)SAGE Open Medicine 2020; 8: 205031212090781 doi: 10.1177/2050312120907811
4
Emre Huri, Yavuz Beyazit, Rashad Mammadov, Sila Toksoz, Ayse B. Tekinay, Mustafa O. Guler, Huseyin Ustun, Murat Kekilli, Mumtaz Dadali, Tugrul Celik, Müzeyyen Astarci, Ibrahim C. Haznedaroglu. Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its HistomorphologicalIn VivoEffects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy ModelInternational Journal of Biomaterials 2013; 2013: 1 doi: 10.1155/2013/949460
5
Fatma Beyazit, Basak Buyuk. An immunohistochemistry and histopathological study of ankaferd blood stopper in a rat model of cervical inflammationRevista da Associação Médica Brasileira 2019; 65(2): 183 doi: 10.1590/1806-9282.65.2.183
6
Louis M. Wong Kee Song, Michael J. Levy. Emerging Endoscopic Therapies for Nonvariceal Upper Gastrointestinal BleedingGastroenterology Clinics of North America 2014; 43(4): 721 doi: 10.1016/j.gtc.2014.08.005
7
T. K. Lim. Edible Medicinal and Non-Medicinal Plants2016; : 178 doi: 10.1007/978-3-319-26065-5_10
8
Tugrul Purnak, Yavuz Beyazit, Ibrahim C. Haznedaroglu. Topical Ankaferd hemostat for the management of clinical bleeding plus hemorrhagic diathesisGastrointestinal Intervention 2013; 2(2): 127 doi: 10.1016/j.gii.2013.09.001
9
Yan-Qing Zhou, Hui Liu, Mu-Xue He, Ruibing Wang, Qing-Qian Zeng, Ying Wang, Wen-Cai Ye, Qing-Wen Zhang. Natural and Artificial Flavoring Agents and Food Dyes2018; : 351 doi: 10.1016/B978-0-12-811518-3.00011-9
10
Alvaro Martínez-Alcalá, Klaus Mönkemüller. Emerging Endoscopic Treatments for Nonvariceal Upper Gastrointestinal HemorrhageGastrointestinal Endoscopy Clinics of North America 2018; 28(3): 307 doi: 10.1016/j.giec.2018.02.004
11
Serkan Torun, Nuretdin SUNA, Ufuk Barış Kuzu, Mahmut Yüksel, Zülfikar Bilge, Onur Aydınlı, Ertuğrul Kayaçetin. Hemoklips ile endoskopik tedaviye rağmen devam eden duodenal ülser kanaması olan bir hastada “Ankaferd Blood Stopper” ile kanama kontrolünün sağlandığı bir olguEndoskopi Gastrointestinal 2015; : 24 doi: 10.17940/endoskopi.466755
12
Engin Koçak, Mustafa Çelebier, Ibrahim C. Haznedaroglu, Sacide Altınöz. Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics ApproachBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5268031
13
Fadi H Mourad, Rupert W Leong. Role of hemostatic powders in the management of lower gastrointestinal bleeding: A reviewJournal of Gastroenterology and Hepatology 2018; 33(8): 1445 doi: 10.1111/jgh.14114
14
Paul Gonzales, Seth Klusewitz, Johanna Marowske, John Gancayco, Michael B. Osswald, Robert Setlik. Everolimus Implicated in Case of Severe Gastrointestinal HemorrhageCase Reports in Oncological Medicine 2017; 2017: 1 doi: 10.1155/2017/3657812
15
Ibrahim Babangida Abubakar, Ibrahim Malami, Yakubu Yahaya, Sahabi Manga Sule. A review on the ethnomedicinal uses, phytochemistry and pharmacology of Alpinia officinarum HanceJournal of Ethnopharmacology 2018; 224: 45 doi: 10.1016/j.jep.2018.05.027
16
Rukiye Hasgul, Sema Uysal, Hacer Haltas, Sumeyye Akyol, Yasemin Yuksel, Ayse Gurel, Ferah Armutcu. Protective effects of Ankaferd blood stopper on aspirin-induced oxidative mucosal damage in a rat model of gastric injuryToxicology and Industrial Health 2014; 30(10): 888 doi: 10.1177/0748233712466134
17
Seyhan Turk, Umit Yavuz Malkan, Mehdi Ghasemi, Helin Hocaoglu, Duygu Mutlu, Gursel Gunes, Salih Aksu, Ibrahim Celalettin Haznedaroglu. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell linesSAGE Open Medicine 2017; 5: 205031211668951 doi: 10.1177/2050312116689519
18
Alan N. Barkun, Sarvee Moosavi, Myriam Martel. Topical hemostatic agents: a systematic review with particular emphasis on endoscopic application in GI bleedingGastrointestinal Endoscopy 2013; 77(5): 692 doi: 10.1016/j.gie.2013.01.020
19
Roxana Ghiulai, Oana Janina Roşca, Diana Simona Antal, Marius Mioc, Alexandra Mioc, Roxana Racoviceanu, Ioana Macaşoi, Tudor Olariu, Cristina Dehelean, Octavian Marius Creţu, Mirela Voicu, Codruţa Şoica. Tetracyclic and Pentacyclic Triterpenes with High Therapeutic Efficiency in Wound Healing ApproachesMolecules 2020; 25(23): 5557 doi: 10.3390/molecules25235557
20
Boon Eu Andrew Kwek, Tiing Leong Ang, Peng Lan Jeannie Ong, Yi Lyn Jessica Tan, Shih Wen Daphne Ang, Ngai Moh Law, Prem Harichander Thurairajah, Kwong Ming Fock. TC-325versusthe conventional combined technique for endoscopic treatment of peptic ulcers with high-risk bleeding stigmata: A randomized pilot studyJournal of Digestive Diseases 2017; 18(6): 323 doi: 10.1111/1751-2980.12481
21
Fatma Beyazit, Yavuz Beyazit, Alpaslan Tanoglu, Ibrahim C. Haznedaroglu. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen contentMedical Hypotheses 2020; 143: 110150 doi: 10.1016/j.mehy.2020.110150
22
Yavuz Beyazit, Fatih Oguz Onder, Serkan Torun, Adnan Tas, Tugrul Purnak, Ilyas Tenlik, Nesrin Turhan. Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleedingBlood Coagulation & Fibrinolysis 2013; 24(7): 762 doi: 10.1097/MBC.0b013e328362d996
23
JoAnn Scurlock. Tigris and Euphrates Rivers: Their Environment from Headwaters to Mouth2021; : 127 doi: 10.1007/978-3-030-57570-0_5
24
Ahmet Koluman, Nejat Akar, Umit Y. Malkan, Ibrahim C. Haznedaroglu. Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric FluidsBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/8957820
25
Ping Ding, Li Yang, Chong Feng, Jian-chun Xian. Research and application of Alpinia officinarum in medicinal fieldChinese Herbal Medicines 2019; 11(2): 132 doi: 10.1016/j.chmed.2019.04.003
26
Hüseyin Sancar BOZKURT. Ankaferd blood stopper: Gastrointestinal kanamalarda yeni bir topikal hemostatik ajanEndoskopi Gastrointestinal 2017; : 89 doi: 10.17940/endoskopi.466637
27
Nabeel Azeem, Martin L. Freeman. Management of Bleeding Patients2021; : 275 doi: 10.1007/978-3-030-56338-7_29
28
Ivo Boškoski, Pietro Familiari, Guido Costamagna. New and emerging endoscopic therapies for gastrointestinal bleedingCurrent Opinion in Gastroenterology 2014; 30(5): 439 doi: 10.1097/MOG.0000000000000105
29
ceylan hepokur, sema mısır, mahmut özbek. Hemostatic Effects of A-fact, which is a new hemostatic agentCumhuriyet Medical Journal 2018;  doi: 10.7197/223.vi.440027